Nature Immunology, Published online: 20 July 2023; doi:10.1038/s41590-023-01551-9Fibrosis, defined by the excess deposition of structural and matricellular proteins in the extracellular space, underlies tissue dysfunction in multiple c…
Nature Immunology, Published online: 20 July 2023; doi:10.1038/s41590-023-01568-0The mechanisms by which TH17 cells can either protect barrier tissues or initiate autoimmunity remain unknown. Here we identify the transcription factor E…
Nature Immunology, Published online: 20 July 2023; doi:10.1038/s41590-023-01574-2Delineation of the steps that lead to immune-related adverse effects indicates that checkpoint-mediated suppression of autoreactive T cells occurs within …
Nature Immunology, Published online: 20 July 2023; doi:10.1038/s41590-023-01573-3Susceptibility to respiratory pathogens is increased during early life, yet children can mount highly effective immune responses to novel pathogens in the…
Nature Immunology, Published online: 18 July 2023; doi:10.1038/s41590-023-01591-1Author Correction: Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors
Nature Immunology, Published online: 17 July 2023; doi:10.1038/s41590-023-01586-yAuthor Correction: Human circulating and tissue-resident memory CD8+ T cells
Nature Immunology, Published online: 17 July 2023; doi:10.1038/s41590-023-01560-8Blish and Lee review the response of natural killer cells to SARS-CoV-2 infection.
Nature Immunology, Published online: 17 July 2023; doi:10.1038/s41590-023-01557-3Young children frequently encounter respiratory pathogens that elicit immune responses in developing lungs. Farber and colleagues examine rare lung tissue…
Nature Immunology, Published online: 17 July 2023; doi:10.1038/s41590-023-01563-5Despite the absence of MHC class II molecules on tumor cells, stem-cell-like CD4+ T cells specific for tumor neoantigens can mediate profound antitumor ef…
Nature Immunology, Published online: 17 July 2023; doi:10.1038/s41590-023-01567-1Tumor cells exploit G-protein-coupled receptor (GPCR) signaling networks to promote angiogenesis, grow and metastasize. We show that tumor cells leverage …